help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published ahead of print on September 10, 2004, doi:10.1164/rccm.200311-1602OC

Am. J. Respir. Crit. Care Med., Volume 170, Number 12, December 2004, 1340-1348

A more recent version of this article appeared on December 15, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200311-1602OCv1
170/12/1340    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Richter, A.
Right arrow Articles by Tuder, R. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richter, A.
Right arrow Articles by Tuder, R. M

Submitted on November 25, 2003
Accepted on September 7, 2004

Impaired Transforming Growth Factor--{beta} Signaling in Idiopathic Pulmonary Arterial Hypertension

Amy Richter1, Michael E Yeager2, Ari Zaiman3, Carlyne D Cool4, Norbert F Voelkel5, and Rubin M Tuder6*

1 Division of Cardiopulmonary Pathology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA, 2 Division of Cardiopulmonary Pathology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Graduate Program in Experimental Pathology, University of Colorado School of Medicine, Denver, CO, USA, 3 Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA, 4 Department of Pathology, University of Colorado School of Medicine, Denver, CO, USA; Pulmonary Hypertension Center, University of Colorado School of Medicine, Denver, CO, USA, 5 Pulmonary Hypertension Center, University of Colorado School of Medicine, Denver, CO, USA; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado School of Medicine, Denver, CO, USA, 6 Division of Cardiopulmonary Pathology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA

* To whom correspondence should be addressed. E-mail: rtuder{at}jhmi.edu.

Mutations in transforming growth factor-{beta} family receptor-II, bone morphogenetic protein receptor-2 and Activin-like kinase1 have been associated with pulmonary hypertension. In the present study, we determined that pulmonary arteries in normal lungs and in lungs of patients with emphysema and idiopathic pulmonary arterial hypertension comparably expressed transforming growth factor-{beta} receptors I and II, Smad(1,5, or 8), Smad2, Smad3, Smad4, phosphorylated Smad(1,5, or 8) and phosphorylated Smad2 (both indicative of active in vivo signaling) in endothelial cells, as assessed by immunohistochemistry and quantitative morphometry. Medial or intimal smooth muscle cells had weak or absent expression of these molecules. In clear contrast to endothelial cell expression in pulmonary arteries and in endothelial cells lining incipient vessels within plexiform lesions of hypertensive lungs, endothelial cells present in the core of the lesions lacked expression of all examined members of the signaling molecules. These findings were irrespective of the mutation status in the bone morphogenetic protein receptor-2 in hypertensive patients. Our findings suggest that pulmonary artery endothelial cells in both normal and severely hypertensive lungs have active transforming growth factor-{beta} family signaling, and that loss of signaling might contribute to the abnormal growth of endothelial cells in plexiform lesions in idiopathic pulmonary arterial hypertension.
Key words: TGF-beta, pulmonary hypertension, endothelial cells, Smad, smooth muscle cells




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
P. R. Rai, C. D. Cool, J. A. C. King, T. Stevens, N. Burns, R. A. Winn, M. Kasper, and N. F. Voelkel
The Cancer Paradigm of Severe Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med., September 15, 2008; 178(6): 558 - 564.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Q. Lu
Transforming growth factor-{beta}1 protects against pulmonary artery endothelial cell apoptosis via ALK5
Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L123 - L133.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. L. Zaiman, M. Podowski, S. Medicherla, K. Gordy, F. Xu, L. Zhen, L. A. Shimoda, E. Neptune, L. Higgins, A. Murphy, et al.
Role of the TGF-{beta}/Alk5 Signaling Pathway in Monocrotaline-induced Pulmonary Hypertension
Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 896 - 905.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Mukhopadhyay, M. Shah, F. Xu, K. Patel, R. M. Tuder, and P. B. Sehgal
Cytoplasmic provenance of STAT3 and PY-STAT3 in the endolysosomal compartments in pulmonary arterial endothelial and smooth muscle cells: implications in pulmonary arterial hypertension
Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L449 - L468.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
B. O. Meyrick, D. B. Friedman, D. D. Billheimer, J. D. Cogan, M. A. Prince, J. A. Phillips III, and J. E. Loyd
Proteomics of Transformed Lymphocytes from a Family with Familial Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med., January 1, 2008; 177(1): 99 - 107.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Zakrzewicz, F. M. Kouri, B. Nejman, G. Kwapiszewska, M. Hecker, R. Sandu, E. Dony, W. Seeger, R. T. Schermuly, O. Eickelberg, et al.
The transforming growth factor-{beta}/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension
Eur. Respir. J., June 1, 2007; 29(6): 1094 - 1104.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. D. Nathan, P. W. Noble, and R. M. Tuder
Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension: Connecting the Dots
Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 875 - 880.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
N. W. Morrell
Pulmonary Hypertension Due to BMPR2 Mutation: A New Paradigm for Tissue Remodeling?
Proceedings of the ATS, November 1, 2006; 3(8): 680 - 686.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
B. Beghe, E. Bazzan, S. Baraldo, F. Calabrese, F. Rea, M. Loy, P. Maestrelli, R. Zuin, L. M. Fabbri, and M. Saetta
Transforming growth factor-{beta} type II receptor in pulmonary arteries of patients with very severe COPD
Eur. Respir. J., September 1, 2006; 28(3): 556 - 562.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. M. Hoeper and L. J. Rubin
Update in pulmonary hypertension 2005.
Am. J. Respir. Crit. Care Med., March 1, 2006; 173(5): 499 - 505.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
K. Teichert-Kuliszewska, M. J.B. Kutryk, M. A. Kuliszewski, G. Karoubi, D. W. Courtman, L. Zucco, J. Granton, and D. J. Stewart
Bone Morphogenetic Protein Receptor-2 Signaling Promotes Pulmonary Arterial Endothelial Cell Survival: Implications for Loss-of-Function Mutations in the Pathogenesis of Pulmonary Hypertension
Circ. Res., February 3, 2006; 98(2): 209 - 217.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. D. Bradley, Y. E. Miller, F. J. Martinez, D. C. Angus, W. MacNee, and E. Abraham
Interstitial Lung Disease, Lung Cancer, Lung Transplantation, Pulmonary Vascular Disorders, and Sleep-disordered Breathing in AJRCCM in 2004
Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 675 - 685.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2004 American Thoracic Society 		  ATS State of the Art 2009